| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/14/2008 | WO2008019065A1 Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 02/14/2008 | WO2008019048A1 Use of aromatase inhibitors for thining the endometrium or treating menorrhagia |
| 02/14/2008 | WO2008019047A2 Reversible inhibition of sperm receptor synthesis for contraception |
| 02/14/2008 | WO2008019025A2 Isoform-selective hdac inhibitors |
| 02/14/2008 | WO2008019010A2 Method of treating thermoregulatory disfunction with paroxetine |
| 02/14/2008 | WO2008018892A2 Methods and kits for treating lacerations and puncture wounds using inverse thermosensitive polymers |
| 02/14/2008 | WO2008018890A2 Methods for fabrication of antimicrobial surfaces |
| 02/14/2008 | WO2008018881A1 6,6-bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors |
| 02/14/2008 | WO2008018877A1 Carnitine conjugates as dual prodrugs, methods of production and uses thereof |
| 02/14/2008 | WO2008018872A1 Therapeutic methods of using estrogen compositions |
| 02/14/2008 | WO2008018843A1 Process for producing useful salts form of biphenyl-tetrazole compounds |
| 02/14/2008 | WO2008018827A1 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders |
| 02/14/2008 | WO2008018825A1 Oral polyvinyl alcohol capsules comprising proton pump inhibitors |
| 02/14/2008 | WO2008018815A1 Mono-and divalent salts of n-(5-hydroxynicotinoil)-l-glutaminic acid exhibiting psychotropic (antidepressant and anxyolytic), neuroprotective, heroprotective and cerebroprotective action |
| 02/14/2008 | WO2008018795A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 02/14/2008 | WO2008018783A2 Porphyrin activation by different spectrum electromagnetical waves-new malignant tumour treatment possibilities |
| 02/14/2008 | WO2008018655A1 Novel thiazole-based compound and inhibitor of t-type calcium channel containing the same |
| 02/14/2008 | WO2008018638A1 Fat absorption inhibitor and food and drink using the same |
| 02/14/2008 | WO2008018592A1 External preparation comprising prostaglandin derivative |
| 02/14/2008 | WO2008018569A1 Pharmaceutical composition |
| 02/14/2008 | WO2008018561A1 Process for production of spherical granule containing slightly water-soluble substance |
| 02/14/2008 | WO2008018556A1 Tablet |
| 02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | WO2008018529A1 Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and pharmaceutical comprising the compound |
| 02/14/2008 | WO2008018517A1 Therapeutic and/or preventive agent for disease accompanied by cell overgrowth, and polynucleotide useful as the active ingredient |
| 02/14/2008 | WO2008018448A1 Activator comprising biosurfactant as the active ingredient, mannosyl erythritol lipid and method of producing the same |
| 02/14/2008 | WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008018426A1 Pyrimidine derivative as pi3k inhibitor and use thereof |
| 02/14/2008 | WO2008018371A1 Oral disintegrating tablet having masked bitter taste and method for production thereof |
| 02/14/2008 | WO2008018306A1 Quinazoline derivative |
| 02/14/2008 | WO2008018275A1 Anti-obesity agent and use thereof |
| 02/14/2008 | WO2008018144A1 Moisturizing agent |
| 02/14/2008 | WO2008018142A1 Antioxidant composition containing component originating in the bark of tree belonging to the genus acacia |
| 02/14/2008 | WO2008018141A1 Composition for preventing and/or treating itching containing component originating in the bark of tree belonging to the genus acacia |
| 02/14/2008 | WO2008018140A1 Composition for preventing and/or treating tumor containing component originating in the bark of tree belonging to the genus acacia |
| 02/14/2008 | WO2008018139A1 Antiobesity composition containing component originating in the bark of tree belonging to the genus acacia |
| 02/14/2008 | WO2008018138A1 Hypoglycemic composition containing component originating in the bark of tree belonging to the genus acacia |
| 02/14/2008 | WO2008018106A1 Alpha lipoic acid combined with dimethylsulfoxide for tropical use |
| 02/14/2008 | WO2008018089A1 R-(-) / s-(+)-7-[3-n-substituted amino-2-hydroxypropoxy] flavones |
| 02/14/2008 | WO2008018085A2 Compositions and methods for treating dermatological abscesses |
| 02/14/2008 | WO2008018063A2 Tetraarylporphine derivatives and uses thereof |
| 02/14/2008 | WO2008017932A2 Heterocycles useful as inhibitors of carbonic anhydrase |
| 02/14/2008 | WO2008017925A2 Pharmacodynamic hybrids endowed of hypoglycemic and no-donor activities obtained combining hydroxylated derivatives of glibenclamide and nitrooxy-substituted carboxylic acids |
| 02/14/2008 | WO2008017886A1 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 02/14/2008 | WO2008017883A2 4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 02/14/2008 | WO2008017867A2 Antiretroviral solid oral composition with at least one water insoluble polymer |
| 02/14/2008 | WO2008017855A1 Osmium compounds |
| 02/14/2008 | WO2008017852A1 Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators |
| 02/14/2008 | WO2008017840A1 Cyclopentanecarboxylic acid derivatives and their use in the treatment of bacterial infectious diseases |
| 02/14/2008 | WO2008017827A2 Azole and thiazole derivatives and their uses |
| 02/14/2008 | WO2008017824A1 Bicyclo [2. 2. 1] hept-7-ylamine derivatives and their use |
| 02/14/2008 | WO2008017814A1 Prevention and treatment of microbial infection |
| 02/14/2008 | WO2008017753A2 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination |
| 02/14/2008 | WO2008017710A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 02/14/2008 | WO2008017696A1 New macrolides useful against inflammatory and allergic disseases |
| 02/14/2008 | WO2008017692A2 Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| 02/14/2008 | WO2008017691A1 Pyridine derivatives as sodium channel blockers |
| 02/14/2008 | WO2008017688A1 2-carboxy thiophene derivatives as anti-viral agents |
| 02/14/2008 | WO2008017685A1 Nitrate esters of piperidines |
| 02/14/2008 | WO2008017670A1 Pyrrolo [3, 2 -d] pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus |
| 02/14/2008 | WO2008017669A1 Purification process of montelukast and its amine salts |
| 02/14/2008 | WO2008017667A1 Process for the purification of montelukast |
| 02/14/2008 | WO2008017658A2 Use of glucocorticoid receptor antagonists for treatment of infectious conditions |
| 02/14/2008 | WO2008017650A1 An aminoisoquinoline thrombin inhibitor with improved bioavailability |
| 02/14/2008 | WO2008017638A1 Single enantiomer beta-agonists, methods for the production thereof and the use thereof as medication |
| 02/14/2008 | WO2008017637A1 Drug combinations for the treatment of respiratory tract diseases |
| 02/14/2008 | WO2008017604A2 Sandalwood aroma receptors |
| 02/14/2008 | WO2008017598A2 Citrusal aroma receptors and use of myrac aldehyde derivatives for increasing the flagellation frequency of a spermatozoon |
| 02/14/2008 | WO2008017594A1 Thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
| 02/14/2008 | WO2008017588A1 Verapamil analogues with inhibition activity on abc (atp binding cassette) cell extrusion pumps |
| 02/14/2008 | WO2008017586A2 Special carbonyl-bis imino compounds for using as p2y11 receptor agonists in the treatment of immune diseases |
| 02/14/2008 | WO2008017521A2 Compositions with enhanced elasticizing activity |
| 02/14/2008 | WO2008017515A1 Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy |
| 02/14/2008 | WO2008017491A1 Ligustilide derivatives for the treatment of disorders of the central nervous system |
| 02/14/2008 | WO2008017473A2 Structure and use of 5' phosphate oligonucleotides |
| 02/14/2008 | WO2008017466A1 Pharmaceutically active tetrahydroisoquinoline-substituted benzimidazole derivatives |
| 02/14/2008 | WO2008017465A1 Bicyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| 02/14/2008 | WO2008017461A1 1, 7-naphthyridine derivatives as p38 map kinase inhibitors |
| 02/14/2008 | WO2008017455A1 Stable and bioavailable compositions of isomers of carotenoids for skin and hair |
| 02/14/2008 | WO2008017451A2 Intermittent treatment with bone anti-resorptive compounds |
| 02/14/2008 | WO2008017415A1 Casein complexes |
| 02/14/2008 | WO2008017390A1 Compositions for the treatment of chronic degenerative inflammatory conditions |
| 02/14/2008 | WO2008017381A1 Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
| 02/14/2008 | WO2008017361A2 2-(heterocyclylbenzyl)pyridazinone derivatives |
| 02/14/2008 | WO2008017337A1 Pharmaceutical composition comprising an active ingredient which neutralizes and/or binds gastric acid, such as an alginic acid derivative |
| 02/14/2008 | WO2008017331A2 Peroral drug form comprising dienogest and ethinyl estradiol for contraception |
| 02/14/2008 | WO2008017278A2 Crystalline tolterodine tartarate and a pharmaceutical composition containing the same |
| 02/14/2008 | WO2008017264A1 Pharmaceutical composition comprising methyl donors or methyl donor enhancers and anti-viral compounds |
| 02/14/2008 | WO2008017216A1 The application of marine steroid in preparing the medicine of treating neurons damaging |
| 02/14/2008 | WO2008017206A1 A percutaneous intratumoral injection composition for treating thyroma |
| 02/14/2008 | WO2008017164A1 Thiophenecarboxamide derivatives as ep4 receptor ligands |
| 02/14/2008 | WO2008017161A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/14/2008 | WO2008017125A1 Targeted polylysine dendrimer therapeutic agent |
| 02/14/2008 | WO2008008493A3 Alkyne-substituted pyridone compounds and methods of use |
| 02/14/2008 | WO2008005954A3 Tryphostin-analogs for the treatment of cell proliferative diseases |
| 02/14/2008 | WO2008005543A3 Compositions with controlled pharmacokinetics |
| 02/14/2008 | WO2008003067A3 Methods and compositions for improved uptake of biological molecules |
| 02/14/2008 | WO2008002571A3 Human protein tyrosine phosphatase inhibitors and methods of use |
| 02/14/2008 | WO2008002570A3 Human protein tyrosine phosphatase inhibitors and methods of use |